181 related articles for article (PubMed ID: 14578863)
21. A Panel of Genes Identified as Targets for 8q24.13-24.3 Gain Contributing to Unfavorable Overall Survival in Patients with Hepatocellular Carcinoma.
Zhao K; Zhao Y; Zhu JY; Dong H; Cong WM; Yu Y; Wang H; Zhu ZZ; Xu Q
Curr Med Sci; 2018 Aug; 38(4):590-596. PubMed ID: 30128866
[TBL] [Abstract][Full Text] [Related]
22. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization.
Naylor TL; Greshock J; Wang Y; Colligon T; Yu QC; Clemmer V; Zaks TZ; Weber BL
Breast Cancer Res; 2005; 7(6):R1186-98. PubMed ID: 16457699
[TBL] [Abstract][Full Text] [Related]
23. Comparative genomic hybridization of hepatocellular carcinoma: correlation with fluorescence in situ hybridization in paraffin-embedded tissue.
Rao UN; Gollin SM; Beaves S; Cieply K; Nalesnik M; Michalopoulos GK
Mol Diagn; 2001 Mar; 6(1):27-37. PubMed ID: 11257209
[TBL] [Abstract][Full Text] [Related]
24. Cytogenetic and molecular genetic alterations in hepatocellular carcinoma.
Lau SH; Guan XY
Acta Pharmacol Sin; 2005 Jun; 26(6):659-65. PubMed ID: 15916730
[TBL] [Abstract][Full Text] [Related]
25. [Correlation of c-myc gene amplification, MTS1/p16 gene alternation, and HBV infection in human hepatocellular carcinoma].
Zhang J; Wang K; Cong S; Qiu F; Wang X; Wang P
Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):294-6. PubMed ID: 11676877
[TBL] [Abstract][Full Text] [Related]
26. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
[TBL] [Abstract][Full Text] [Related]
27. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.
Squire JA; Pei J; Marrano P; Beheshti B; Bayani J; Lim G; Moldovan L; Zielenska M
Genes Chromosomes Cancer; 2003 Nov; 38(3):215-25. PubMed ID: 14506695
[TBL] [Abstract][Full Text] [Related]
28. Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma.
Yuan BZ; Zhou X; Zimonjic DB; Durkin ME; Popescu NC
J Mol Diagn; 2003 Feb; 5(1):48-53. PubMed ID: 12552080
[TBL] [Abstract][Full Text] [Related]
29. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
Chan KL; Guan XY; Ng IO
Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
[TBL] [Abstract][Full Text] [Related]
30. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
[TBL] [Abstract][Full Text] [Related]
31. A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study.
Chochi Y; Kawauchi S; Nakao M; Furuya T; Hashimoto K; Oga A; Oka M; Sasaki K
J Pathol; 2009 Apr; 217(5):677-84. PubMed ID: 19097070
[TBL] [Abstract][Full Text] [Related]
32. High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1.
Karlsson E; Waltersson MA; Bostner J; Pérez-Tenorio G; Olsson B; Hallbeck AL; Stål O
Genes Chromosomes Cancer; 2011 Oct; 50(10):775-87. PubMed ID: 21748818
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of glycosyl-phosphatidylinositol anchor attachment protein 1 (GPAA1) is associated with gene amplification in hepatocellular carcinoma.
Ho JC; Cheung ST; Patil M; Chen X; Fan ST
Int J Cancer; 2006 Sep; 119(6):1330-7. PubMed ID: 16642471
[TBL] [Abstract][Full Text] [Related]
34. Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.
Courjal F; Theillet C
Cancer Res; 1997 Oct; 57(19):4368-77. PubMed ID: 9331100
[TBL] [Abstract][Full Text] [Related]
35. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
[TBL] [Abstract][Full Text] [Related]
36. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
[TBL] [Abstract][Full Text] [Related]
37. Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH.
Hashimoto K; Mori N; Tamesa T; Okada T; Kawauchi S; Oga A; Furuya T; Tangoku A; Oka M; Sasaki K
Mod Pathol; 2004 Jun; 17(6):617-22. PubMed ID: 15133472
[TBL] [Abstract][Full Text] [Related]
38. Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization.
Steinemann D; Skawran B; Becker T; Tauscher M; Weigmann A; Wingen L; Tauscher S; Hinrichsen T; Hertz S; Flemming P; Flik J; Wiese B; Kreipe H; Lichter P; Schlegelberger B; Wilkens L
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1283-91. PubMed ID: 16979954
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray.
Wang Y; Wu MC; Sham JS; Zhang W; Wu WQ; Guan XY
Cancer; 2002 Dec; 95(11):2346-52. PubMed ID: 12436441
[TBL] [Abstract][Full Text] [Related]
40. Dual fluorescence in situ hybridization in detection of HER-2 oncogene amplification in primary hepatocellular carcinoma.
Huang TJ; Huang BJ; Liang QW; Huang CW; Fang Y
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):62-8. PubMed ID: 14969840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
